AGA Family of Websites:

The next great idea in GI tech may be yours

Do you have a great idea that may modernize, even revolutionize an aspect of GI care? Why not share it at AGA’s Shark Tank competition before the Feb. 1, 2019, application deadline.

Gastroenterology is a field that is continually adapting new tools, methodologies and technologies to improve how clinicians deliver patient care. Many innovations come from GI practitioners, like yourself, who have identified more effective ways to deliver results for their patients.


The Shark Tank is part of AGA’s annual Tech Summit which bridges the divide between a growing need for new clinical tools and the ability to move innovative solutions to market. By coming together and moving forward to foster collaborations among innovators, clinicians, medical technology companies, regulators and venture capitalists, AGA is working to grow a pipeline for GI innovation to improve delivery of care and patient outcomes.


At the Shark Tank, GI innovators and entrepreneurs can seek advice from experts and exposure for their innovative medical device or technology idea. Up to five applicants will be selected to give a five-minute presentation of their innovation to a panel of judges. The winner will receive an award and promotion via AGA publications and social media channels. Up to 10 additional applicants not selected to present will be invited to participate in the Shark Tank Poster Session.


Register by Feb. 11, 2019, to take advantage of the early bird rate where 2019 attendees will enjoy sessions on:

    • How artificial intelligence and machine learning may improve patient outcomes. 
    • Potential innovative solutions in simulation-based training.
    • Exploring the challenges of achieving a viable endoscopic anti-reflux procedure.
    • Learning how to leverage mobile apps, virtual reality and telemedicine to improve patient compliance, engagement and show rates.

AGA clinical guidance

Find the latest evidence-based recommendations for treating your patients.